October 2, 2020
Patients receiving care for advanced cancer at Moores Cancer Center at UC San Diego Health were more likely to survive or experience a longer period without their disease progressing if they received personalized cancer therapy.
February 13, 2018
Armed with skill, special tools and light, University of California San Diego Associate Professor Neal Devaraj and a group of his chemistry graduate students activated cellular gene expression with unique precision. By modifying messenger RNA (mRNA)—a group of molecules that carries genetic information from DNA to ribosomes where specifications of…
January 9, 2012
A team of scientists, led by researchers at the University of California, San Diego School of Medicine and Zacharon Pharmaceuticals, have developed a simple, reliable test for identifying biomarkers for mucopolysaccharidoses (MPS), a group of inherited metabolic disorders that are currently diagnosed in patients only after symptoms have become serious…
February 4, 2013
The National Institute of Mental Health has awarded a $3.4 million grant to a team of researchers at the University of California, San Diego School of Medicine to study successful aging in HIV-infected adults. HIV is a serious, chronic, medical disease that affects the lives of more than one million…
March 4, 2021
Exercise has long-been recommended as a cognitive-behavioral therapy for patients of depression, yet new evidence from the University of California of San Diego suggests that the COVID-19 pandemic changed the nature of the relationship between physical activity and mental health.
April 16, 2015
…latest care and newest therapies.” “Their clinic benefits from research into novel approaches that advance our knowledge and their research agenda reflects the priorities of patients and families,” he said. Higgins puts it this way: “I know good people attract good people. The Center of Excellence will bring in smarter…
April 1, 2024
UC San Diego researcher, Farah Sheikh, studies a genetic heart arrhythmia condition that usually strikes people under 40. Her research will be used in clinical trials of a treatment for ARV.
March 1, 2012
UC San Diego Moores Cancer Center researchers and surgeons are among the first in the nation to treat patients with recurrent brain cancer by directly injecting an investigational viral vector into their tumor. The treatment is being developed by a local San Diego Company, Tocagen Inc.
May 9, 2022
An international team of researchers, led by scientists at UC San Diego, report that a gene therapy that inhibits targeted nerve cell signaling effectively reduced neuropathic pain with no detectable side effects in mice with spinal cord or peripheral nerve injuries.
October 17, 2019
…Patients to Latest Cancer Therapies Using a personalized approach, Moores Cancer Center at UC San Diego Health employs genetic profiling to treat patients who have not responded to, or relapsed from, standard treatments A third occurrence of colon cancer and a failed immunotherapy clinical trial left Gordon Levine confined to…
